Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. (Q40274571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Corina M Borza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ambra Pozzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Dorin-Bogdan Borza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Vadim Pedchenko

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Roy Zent

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

26 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

20932-20939

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Distinct antitumor properties of a type IV collagen domain derived from basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Novel roles for alpha3beta1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Complex interactions between the laminin alpha 4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

Extracellular Matrix-derived Peptide Binds to αvβ3Integrin and Inhibits Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601147200

21 January 2018

Identifiers

DOI

10.1074/JBC.M601147200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16731529%20AND%20SRC:MED&resulttype=core&format=json